B. Godbert

1.2k total citations · 1 hit paper
19 papers, 552 citations indexed

About

B. Godbert is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, B. Godbert has authored 19 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in B. Godbert's work include Lung Cancer Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). B. Godbert is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Lung Cancer Treatments and Mutations (4 papers). B. Godbert collaborates with scholars based in France, United States and Belgium. B. Godbert's co-authors include Jean-Michel Vignaud, Marie-Pierre Wissler, Jiping Zha, Premal H. Patel, Ramaswamy Govindan, Fabrice Barlési, Amy Peterson, G. Robinet, Wei Yu and George R. Blumenschein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

B. Godbert

16 papers receiving 536 citations

Hit Papers

Randomized Phase II Trial of Onartuzumab in Combination W... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
    2013 370 citations David R. Spigel, Thomas J. Ervin et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Godbert France 7 325 207 151 143 73 19 552
Antonio Picardo Spain 9 98 0.3× 148 0.7× 85 0.6× 97 0.7× 107 1.5× 21 358
Edith K.Y. Tin Hong Kong 6 311 1.0× 220 1.1× 124 0.8× 115 0.8× 99 1.4× 6 582
Dae‐Won Lee South Korea 14 176 0.5× 426 2.1× 47 0.3× 281 2.0× 158 2.2× 46 842
Selena Y. Lin United States 14 119 0.4× 128 0.6× 108 0.7× 281 2.0× 75 1.0× 35 557
Masatoshi Deguchi Japan 14 48 0.1× 110 0.5× 158 1.0× 257 1.8× 128 1.8× 42 643
Martin Krüger Germany 12 257 0.8× 193 0.9× 381 2.5× 301 2.1× 325 4.5× 13 890
Surasak Leelaudomlipi Thailand 11 65 0.2× 63 0.3× 250 1.7× 114 0.8× 255 3.5× 27 565
T. T. Wu United States 11 292 0.9× 138 0.7× 61 0.4× 102 0.7× 235 3.2× 13 596
Christopher Di Simone United States 7 107 0.3× 274 1.3× 33 0.2× 114 0.8× 43 0.6× 10 591
Junji Shibata Japan 10 63 0.2× 74 0.4× 262 1.7× 96 0.7× 76 1.0× 22 577

Countries citing papers authored by B. Godbert

Since Specialization
Citations

This map shows the geographic impact of B. Godbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Godbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Godbert more than expected).

Fields of papers citing papers by B. Godbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Godbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Godbert. The network helps show where B. Godbert may publish in the future.

Co-authorship network of co-authors of B. Godbert

This figure shows the co-authorship network connecting the top 25 collaborators of B. Godbert. A scholar is included among the top collaborators of B. Godbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Godbert. B. Godbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Molinier, O., J. Pinsolle, Sebastian Schneider, et al.. (2024). COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study. Respiratory Medicine and Research. 86. 101093–101093. 1 indexed citations
4.
Debieuvre, D., I. Monnet, Olivier Bylicki, et al.. (2023). Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.. Journal of Clinical Oncology. 41(16_suppl). 8542–8542.
5.
6.
Decker, Paul A., Vincent Sobanski, T. Moulinet, et al.. (2021). Interstitial pneumonia with autoimmune features: Evaluation of connective tissue disease incidence during follow-up. European Journal of Internal Medicine. 97. 62–68. 7 indexed citations
7.
Nasser, Mouhamad, Y. Uzunhan, Sandrine Hirschi, et al.. (2021). Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort. OA4236–OA4236. 1 indexed citations
8.
Godbert, B., et al.. (2020). Hepatitis B reactivation and immune check point inhibitors. Digestive and Liver Disease. 53(4). 452–455. 18 indexed citations
9.
Maurier, F., B. Godbert, & Julie Perrin. (2020). Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection. SHILAP Revista de lepidopterología. 7(6). 1728–1728. 20 indexed citations
10.
Godbert, B., et al.. (2018). Radiation Recall Pneumonitis in A PatientTreated by Nivolumab for Non-Small CellLung Cancer, No Relapse with Rechallenge. 1(3). 7 indexed citations
11.
Huet, D., et al.. (2016). Infection pulmonaire à Mycobacterium malmoense . Difficultés diagnostiques et de thérapeutiques. Revue des Maladies Respiratoires. 34(3). 257–261. 1 indexed citations
12.
Huet, D., et al.. (2015). Infection pulmonaire à Mycobacterium malmoense, difficultés diagnostiques et de thérapeutiques. Revue des Maladies Respiratoires. 33. A235–A235. 1 indexed citations
13.
Saussereau, Emilie, Isabelle Vachier, R. Chiron, et al.. (2014). Effectiveness of bacteriophages in the sputum of cystic fibrosis patients. Clinical Microbiology and Infection. 20(12). O983–O990. 54 indexed citations
14.
Godbert, B., Marie-Pierre Wissler, & Jean-Michel Vignaud. (2013). Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. European Respiratory Review. 22(128). 117–123. 60 indexed citations
15.
Godbert, B., Angélica Tiotiu, Camila Masias, & Y. Martinet. (2013). Sécrétion d’hormone chorionique gonadotrope β au cours des cancers bronchiques. Revue de Pneumologie Clinique. 69(5). 298–301. 2 indexed citations
16.
Spigel, David R., Thomas J. Ervin, Rodryg Ramlau, et al.. (2013). Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 31(32). 4105–4114. 370 indexed citations breakdown →
17.
Clément-Duchêne, Christelle, B. Godbert, & Y. Martinet. (2012). Thérapeutiques antiangiogéniques dans le cancer bronchique : indications et toxicités. Revue des Maladies Respiratoires. 29(2). 161–177. 2 indexed citations
18.
Durand, Marion, et al.. (2011). Large thoracomyoplasty and negative pressure therapy for late postpneumonectomy empyema with a retrosternal abscess: a modern version of the Clagett procedure. Interactive Cardiovascular and Thoracic Surgery. 12(5). 888–889. 4 indexed citations
19.
Godbert, B., Christelle Clément-Duchêne, D. Régent, & Y. Martinet. (2010). Pneumopathie organisée cryptogénique : biopsie et corticoïdes sont-ils constamment utiles ?. Revue des Maladies Respiratoires. 27(5). 509–514. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Picardo Breakdown of academic impact, for papers by Edith K.Y. Tin Breakdown of academic impact, for papers by Dae‐Won Lee Breakdown of academic impact, for papers by Selena Y. Lin Breakdown of academic impact, for papers by Masatoshi Deguchi Breakdown of academic impact, for papers by Martin Krüger Breakdown of academic impact, for papers by Surasak Leelaudomlipi Breakdown of academic impact, for papers by T. T. Wu Breakdown of academic impact, for papers by Christopher Di Simone Breakdown of academic impact, for papers by Junji Shibata
Rankless by CCL
2026